WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000059932) INFLUENZA VIRUS HEMAGGLUTININ-BINDING PEPTIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/059932    International Application No.:    PCT/JP2000/001867
Publication Date: 12.10.2000 International Filing Date: 27.03.2000
Chapter 2 Demand Filed:    13.04.2000    
IPC:
A61K 38/00 (2006.01), C07K 7/08 (2006.01)
Applicants: OTSUKA PHARMACEUTICAL CO., LTD. [JP/JP]; 9, Kandatsukasacho 2-chome, Chiyoda-ku, Tokyo 101-8535 (JP) (For All Designated States Except US).
SATO, Toshinori [JP/JP]; (JP) (For US Only).
ISHIKAWA, Dai [JP/JP]; (JP) (For US Only).
TANAKA, Michinori [JP/JP]; (JP) (For US Only).
OGINO, Koichi [JP/JP]; (JP) (For US Only).
TAKI, Takao [JP/JP]; (JP) (For US Only)
Inventors: SATO, Toshinori; (JP).
ISHIKAWA, Dai; (JP).
TANAKA, Michinori; (JP).
OGINO, Koichi; (JP).
TAKI, Takao; (JP)
Agent: SAEGUSA, Eiji; Kitahama TNK Building, 1-7-1, Doshomachi, Chuo-ku, Osaka-shi, Osaka 541-0045 (JP)
Priority Data:
11/91962 31.03.1999 JP
Title (EN) INFLUENZA VIRUS HEMAGGLUTININ-BINDING PEPTIDES
(FR) PEPTIDES SE LIANT A L'HEMAGGLUTININE DU VIRUS DE LA GRIPPE
Abstract: front page image
(EN)Influenza virus hemagglutinin-binding peptides having amino acid sequences represented by, for example, SEQ ID NOS: 1 to 11. These peptides can bind specifically to hemagglutinin participating in the first step of the infection with influenza virus and thus inhibit the binding of the virus to the receptor of the host. Thus, these peptides are useful as preventives for the infection with influenza virus and remedies for influenza.
(FR)L'invention concerne des peptides se liant à l'hémagglutinine du virus de la grippe, présentant des séquences d'acides aminés représentées par, par exemple, SQ ID NOS : 1 à 11. Ces peptides peuvent se lier spécifiquement à l'hémagglutinine participant à la première phase de l'infection par le virus de la grippe et inhiber ainsi la liaison du virus au récepteur de l'hôte. Ainsi, ces peptides sont utiles en tant qu'agents préventifs de l'infection par le virus de la grippe et en tant que remèdes contre la grippe.
Designated States: AU, CA, CN, JP, KR, MX, US.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)